Silencing Mutant Htt by AAV-Mediated Expression of RNAi Ameliorates Disease Manifestations in the YAC128 Mouse Model of Huntington's Disease

被引：0
|
作者：
Stanek, Lisa M. [1 ]
Shihabuddin, Lamya S. [1 ]
Cheng, Seng H. [1 ]
机构：
[1] Genzyme Corp, Rare Dis Sci, Framingham, MA 01701 USA
来源：
MOLECULAR THERAPY | 2013年 / 21卷
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
282
引用
收藏
页码：S108 / S108
页数：1
相关论文
共 50 条
  • [21] Cortical thickness measured from MRI in the YAC128 mouse model of Huntington's disease
    Lerch, Jason P.
    Carroll, Jeffrey B.
    Dorr, Adrienne
    Spring, Shoshana
    Evans, Alan C.
    Hayden, Michael R.
    Sled, John G.
    Henkelman, R. Mark
    NEUROIMAGE, 2008, 41 (02) : 243 - 251
  • [22] Temporal Characterization of Behavioral and Hippocampal Dysfunction in the YAC128 Mouse Model of Huntington's Disease
    Nascimento-Castro, Cristine De Paula
    Winkelmann-Duarte, Elisa C.
    Mancini, Gianni
    Welter, Priscilla Gomes
    Placido, Evelini
    Farina, Marcelo
    Gil-Mohapel, Joana
    Rodrigues, Ana Lucia S.
    de Bem, Andreza Fabro
    Brocardo, Patricia S.
    BIOMEDICINES, 2022, 10 (06)
  • [23] ALTERNATIVE PROCESSING OF HUMAN HTT MRNA IN YAC128 MICE: IMPLICATIONS FOR HUNTINGTON'S DISEASE THERAPEUTICS
    Fienko, Sandra
    Landles, Christian
    Sathasivam, Kirupa
    Gomez-Paredes, Casandra
    McAteer, Sean
    Milton, Rebecca
    Osborne, Georgina F.
    Jones, Samuel T.
    Phillips, Jemima M.
    Kordasiewicz, Holly B.
    Bates, Gillian P.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 : A1 - A2
  • [24] AAV-RNAi Mediated Lowering of HTT for the Treatment of Huntington's Disease
    Adams, Johanna
    Richards, Brenda
    O'Riordan, Catherine
    Goulet, Martin
    Jackson, Robert G.
    Bladon, John
    He, Ye
    Luo, Zhengyu
    Mueller, Christian
    Ramachandran, Shyam
    Elmer, Bradford
    MOLECULAR THERAPY, 2024, 32 (04) : 321 - 321
  • [25] Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease
    Van Raamsdonk, JM
    Pearson, J
    Slow, EJ
    Hossain, SM
    Leavitt, BR
    Hayden, MR
    JOURNAL OF NEUROSCIENCE, 2005, 25 (16): : 4169 - 4180
  • [26] Manganese Differentially Regulates Dopaminergic Dynamics and Behavior in the YAC128 Mouse Model of Huntington's Disease
    Wilcox, Jordyn
    Consoli, David
    Debbiche, Ines
    Calipari, Erin
    Bowman, Aaron
    Harrison, Fiona
    FREE RADICAL BIOLOGY AND MEDICINE, 2020, 159 : S83 - S84
  • [27] Altered adult hippocampal neurogenesis in the YAC128 transgenic mouse model of Huntington disease
    Simpson, Jessica M.
    Gil-Mohapel, Joana
    Pouladi, Mahmoud A.
    Ghilan, Mohamed
    Xie, Yuanyun
    Hayden, Michael R.
    Christie, Brian R.
    NEUROBIOLOGY OF DISEASE, 2011, 41 (02) : 249 - 260
  • [28] Antisense oligonucleotide-mediated disruption of HTT caspase-6 cleavage site ameliorates the phenotype of YAC128 Huntington disease mice
    Kuijper, Elsa C.
    Overzier, Maurice
    Suidgeest, Ernst
    Dzyubachyk, Oleh
    Maguin, Cecile
    Perot, Jean-Baptiste
    Flament, Julien
    Ariyurek, Yavuz
    Mei, Hailiang
    Buijsen, Ronald A. M.
    van der Weerd, Louise
    van Roon-Mom, Willeke
    NEUROBIOLOGY OF DISEASE, 2024, 190
  • [29] Striosome-matrix pathology and motor deficits in the YAC128 mouse model of Huntington's disease
    Lawhorn, Collene
    Smith, Diane M.
    Brown, Lucy L.
    NEUROBIOLOGY OF DISEASE, 2008, 32 (03) : 471 - 478
  • [30] Age-Dependent Alterations of Corticostriatal Activity in the YAC128 Mouse Model of Huntington Disease
    Joshi, Prasad R.
    Wu, Nan-Ping
    Andre, Veronique M.
    Cummings, Damian M.
    Cepeda, Carlos
    Joyce, John A.
    Carroll, Jeffrey B.
    Leavitt, Blair R.
    Hayden, Michael R.
    Levine, Michael S.
    Bamford, Nigel S.
    JOURNAL OF NEUROSCIENCE, 2009, 29 (08): : 2414 - 2427
12345